NCCN, ESMO and Cancer Australia recognize scalp cooling as standard of care

National Comprehensive Cancer Network® (NCCN)

• Scalp cooling is a Category 2A recommendation to reduce the incidence of chemotherapy-induced alopecia for patients receiving chemotherapy.

• For NCCN scalp cooling recommendations view the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®)

  – Breast cancer (Version 1.2019) – Category 2A recommendation

  – Ovarian cancer (Version 1.2020) – Category 2A recommendation

European Society for Medical Oncology (ESMO)

• Scalp cooling is a Category IIB treatment recommendation 
• Multidisciplinary group of oncology experts from Europe, the United States and Australia authored the recommendation
• ESMO Clinical Practice Guidelines – Prevention and management of dermatological toxicities related to anticancer agents (November 2020)

Cancer Australia

• Fall 2020 update
• Guidance for the management of early breast cancer patients